Evaluation of Blood Loss After Cesarean Delivery Via US Compared to Standard Care
Recruiting
N/A
Interventional Study
Postpartum Period
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 50
- Sex
- Female
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 276 (estimated)
- Sponsor
- Holy Family Hospital, Nazareth, Israel · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Postpartum hemorrhage and anemia are considered a major health concern due to their impact on maternal morbidity and mortality, quality of life, and maternal cognitive and emotional functioning after delivery, which are particularly important during the critical period of mother-child bonding. Hemoglobin levels in the first 24 hours after delivery do not reflect the lowest point (nadir). The postp…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Women who delivered by a cesarean section.
* Age over 18.
* Fluent in Hebrew or Arabic.
* Signed informed consent form.
Exclusion Criteria:
* Lack of consent or inability to provide informed consent.
* Inability to perform a post-surgical ultrasound, such as post-surgery hos…
Contacts